Precision Medicine

Personalized Treatments

Read More

Early Detection

Discovering Biomarkers

Read More

Novel Intervention

Non-invasive, Long-lasting

Read More

Our primary mission is to understand the brain basis of psychiatric disorders and to promote translation of this knowledge into clinical practice.

Towards this end, we employ multimodal neuroimaging techniques to investigate the pathophysiology of psychiatric and neurodevelopmental disorders such as schizophrenia, depression, bipolar disorder, anxiety, and ADHD.

Our ultimate mission is to discover biomarkers for improved diagnosis, early detection (potentiating early intervention and possibly prevention), prediction of therapeutic response (targeted towards precision medicine) as well as developing novel therapeutic techniques (e.g., real-time fMRI feedback) with the hope of improving (or augmenting) currently available treatments.